Incheon National University Scientists Review Progress in Promising Anticancer Compounds
Retrieved on:
Wednesday, January 26, 2022
In a recent review article published in Coordination Chemistry Reviews , a team of scientists led by Professors Chang Yeon Lee and Gajendra Gupta of Incheon National University, Korea, discussed the evolution and recent progress in the field of BODIPY-based MOCs and MOFs, with a focus on the compounds' potential roles as both anticancer drugs and tools for cancer research.
Key Points:
- In a recent review article published in Coordination Chemistry Reviews , a team of scientists led by Professors Chang Yeon Lee and Gajendra Gupta of Incheon National University, Korea, discussed the evolution and recent progress in the field of BODIPY-based MOCs and MOFs, with a focus on the compounds' potential roles as both anticancer drugs and tools for cancer research.
- The article explains the compounds' various advantages and synergies with other medical techniques and also addresses the major roadblocks to their widespread application.
- Both are widely used in biomedicine and have shown potential as anticancer agents with good selectivity.
- "MOCs and MOFs designed with BODIPY have all the essential features required to be an ideal anticancer drug candidate," concludes Prof. Gupta.